Kidney paired donation

Last updated

Kidney paired donation (KPD), or paired exchange, is an approach to living donor kidney transplantation where patients with incompatible donors swap kidneys to receive a compatible kidney. KPD is used in situations where a potential donor is incompatible. Because better donor HLA and age matching are correlated with lower lifetime mortality [1] and longer lasting kidney transplants, [2] many compatible pairs are also participating in swaps to find better matched kidneys. In the United States, the National Kidney Registry organizes the majority of U.S. KPD transplants, [3] [4] [5] including the largest swaps. The first large swap was a 60 participant chain in 2012 that appeared on the front page of the New York Times [6] and the second, even larger swap, included 70 participants and was completed in 2014. [7] Other KPD programs in the U.S. include the UNOS program, which was launched in 2010 and completed its 100th KPD transplant in 2014, [8] [9] and the Alliance for Paired Donation. [10]

Contents

According to a 2019 study, kidney exchanges improve overall transplant quality, which leads to fewer transplant failures. The exchanges also reduce waiting times for patients needing kidney transplants. The study found that the health care cost savings of kidney exchanges are substantial. [11]

Types of swaps

Swaps of kidneys come in two distinct types: cycles and chains. Cycles only include donors who are paired with a patient so that the donor donates a kidney only if their patient receives a kidney in the swap. Chains are initiated by non-directed donors. These donors, also known as unpaired or altruistic donors, donate a kidney without any expectation of a reciprocal kidney donation to any specific patient.

Reasons

More than one-third of potential living kidney donors who want to donate their kidney to a friend or family member cannot donate due to blood type or antibody incompatibility. [12] Historically, these donors would be turned away and the patient would lose the opportunity to receive a life-saving transplant. KPD overcomes donor–recipient incompatibility by swapping kidneys between multiple donor–recipient pairs. KPD is also being used to find better donor–recipient matches for compatible pairs who want a lower lifetime mortality [1] [13] and longer lasting transplant. [2]

History

YearEvent
1986KPD first suggested by Rapaport [14]
1991First KPD program started in South Korea by Dr. Park [8]
1999First European KPD transplants performed in Switzerland [8]
2000First KPD transplants performed in U.S. at the Rhode Island Hospital [8]
2001Hopkins completes KPD transplants and begins first KPD program in U.S. [15]
2004Dutch established first national KPD program [8]
2007NEAD chain started by APD utilizing first bridge donor [16]
2007Charlie Norwood Living Organ Donation Act clarifies legality of KPD in U.S. [17]
2008National Kidney Registry organizes its first transplants on Valentine's Day [18]
2009Hopkins leads first 16 patient multicenter Domino Chain [19] [20]
2010UNOS organizes its first KPD transplants [8]
2012National Kidney Registry completes largest chain involving 60 participants [6]
2014National Kidney Registry sets new record with 70 participant chain [7]
2017First Academic Paper published on “Chronological Incompatibility” outlining the ADP Voucher Program” [21]

Early days

The first paper outlining the concept of paired exchange was authored by FT Rapaport and published in 1986. [22] [14] The first recorded paired exchange transplants were organized in South Korea by Dr. Park beginning in 1991. [8] For nearly a decade, only Park and his team in South Korea utilized this novel approach to facilitate transplants for incompatible donor–recipient pairs. In 1999, the first KPD transplants were performed in Europe [8] followed by the first KPD transplants in the United States in 2000. [8] Over the next ten years the United States would become the most competitive KPD market in the world with more than a dozen KPD programs commencing operations and many KPD programs failing. Outside of the United States, most of the KPD programs have been organized or sponsored by governments which has limited innovation in these programs. Three of the important early KPD programs in the U.S. were the Hopkins program led by Dr. Montgomery and Dr. Segev, [23] the New England Paired Kidney Exchange (NEPKE) led by Dr. Delmonico and Professor Alvin Roth [24] and the Ohio Organ Consortium which later reorganized as two competing programs, the Paired Donation Network (PDN) led by Dr. Woodle [25] and the Alliance for Paired Exchange (APD) led by Dr. Rees. [26]

The Hopkins program, which was based out of the Johns Hopkins Hospital, led the industry in early innovations including the critical "domino chain" breakthrough which allowed Good Samaritan donors to start chains, [27] dramatically increasing the number of pairs that could be matched in a swap compared to the loop approach that was used previously. Once the Hopkins team began organizing Domino Chains, these swaps became larger and began attracting national media attention due to the massive complexity and significant impact of these large swaps. Unlike the Hopkins program that was hospital based, NEPKE was launched within the New England Organ Procurement Organization which served several states in the North East. The PDN and APD organizations were founded by transplant surgeons but attempted to create networks of transplant centers that would work together to pool their incompatible pairs, much like NEPKE but without OPO support.

In 2006, the APD conceived of a critically important innovation called "NEAD Chains" that amplified the matching power of Domino Chains by allowing Bridge Donors to extend chains. Prior to the utilization of Bridge Donors, a chain of transplant surgeries would be completed in one day, which limited the number of transplants that could be performed. A bridge Donor is someone whose paired recipient has received a kidney but does not donate for some period of time (generally 1 week to 3 months). Just like Domino Chains increased KPD transplants, the utilization of bridge donors also dramatically increased KPD transplants because chains could now be organized over several months and avoid the logistical limitations of performing all surgeries on one day. In 2007, the APD completed the first NEAD chain. [16] That same year, the U.S. Congress passed the Charlie Norwood Act [17] which clarified that paired exchange was legal. Prior to the passage of this law, many in the U.S. transplant community feared that KPD was unlawful due to the prohibition of "valuable consideration" as articulated in the NOTA laws that govern the U.S. transplant industry. [28] With the passage of the Charlie Norwood Act, many more KPD programs were launched in the U.S. including the UNOS KPD program which was government sponsored [29] with funding from deceased donor registration fees and charitable contributions.

Break out phase

In 2007 Garet and Jan Hil founded the National Kidney Registry (NKR) after their daughter (age 10) lost her kidney function and needed a transplant. Both parents were incompatible and could not donate to their daughter, who later, after an extensive donor search, received a living donor kidney from her compatible cousin. Mr. Hil was the first non-physician to start/lead a KPD program and the first KPD leader to donate one of his kidneys, starting a chain that facilitated eight transplants. In 2008 the National Kidney Registry completed its first KPD transplants and implemented the next major innovation, the shipment of kidneys on commercial airlines. This breakthrough in logistics further expanded KPD. The first living donor kidney that was shipped on a commercial airline went from New York to Los Angeles [30] and started NKR's second chain which facilitated eight transplants utilizing several bridge donors. Initially NKR provided donors with the option of traveling to the matched recipient's hospital or donating locally and having their kidney shipped. Recipients could also choose if they would accept a shipped kidney or require the donor to travel to their center to donate. Over a two-year period, these preferences shifted until nearly all recipients would accept shipped kidneys with very few donors willing to travel. By 2010 the option to have a donor travel was phased out and all kidneys that needed to be moved between centers were shipped. After several near misses and with the UNOS reporting that 1–2% of deceased donor kidney lost or mis-routed, the NKR developed the first GPS tracking systems for human organs to monitor the location of all NKR kidney shipments. [31] The utilization of GPS tracking devices is now mandatory for all NKR shipped kidneys.

In 2009 several more key innovations were yielding results at a single center KPD program, the Methodist Transplant Institute, in San Antonio led by Dr. Adam Bingaman. Prior to Dr. Bingaman's work, KPD was built on the notion that the results of a cross match test to determine donor–recipient compatibility are generally predictable and to ensure the prediction is accurate, a cross match test must be completed prior to the swap. In 5–10% of the cases, these cross match tests result in an unexpected positive cross match (bad) which causes a swap to fail. These swap failures are costly in terms of wasted time and testing but they are also demoralizing for the patients and donors involved in the cancelled swap. The Methodist program implemented the first donor blood cryo-preservation allowing the rapid cross matching of pairs in a swap without requiring fresh blood from donors. This approach accelerates the matching process, reduces swap failure rates and provides the ability to speculatively cross match potential donors for highly sensitized patients, leading to shorter wait times and more transplants for highly sensitized patients. Although the merits of using cryo-preserved donor blood for cross matching were clear, it proved difficult for multi-center KPD programs to implement cryo-preservation due to the complexity of the multi-center environment. The only U.S. multi-center KPD program that successfully implemented cryo-preservation was the National Kidney Registry [32] but only after establishing a central lab and investing three years in software development. The second important innovation implemented in San Antonio was the re-engineering of the donor/patient intake process to educate and enroll compatible pairs in KPD so that the compatible recipient can get a better matched donor kidney. The development of cryo-preservation based cross matching and the systematic enrollment of compatible pairs has helped make San Antonio one of the leading KPD centers in the U.S.

By 2010 the UNOS KPD program had completed its first swap [33] and the NEPKE and PDN programs folded due to funding issues and increased regulatory requirements imposed on U.S. KPD programs by CMS and UNOS. During this time, the NKR developed the first donor preselect system that allowed donors to be accepted or declined before a match was offered. This innovation was taken from the brokerage industry, essentially porting the limit order concept to KPD. The preselect concept eliminated the need to use supercomputers for match runs because the number of valid one-ways was dramatically reduced. The donor preselect concept developed by the NKR was quickly copied by other major KPD programs and changed the nature of the mathematics needed to support KPD by dramatically reducing the number of one-way match possibilities.

In 2012 the National Kidney registry organized the largest swap in history which included 60 surgeries, completed over five months. [6] That same year the NKR initiated the Advanced Donation Program (ADP) which inverted the role of the bridge donor – now donors were donating in advance of their paired recipient transplants [34] which further alleviated scheduling challenges for paired donors. In 2014, the National Kidney Registry set a new record by organizing a swap that included 70 surgeries completing over two months. [7] That same year, the NKR completed its first long term Advanced Donation whereby a donor donated on behalf of his grandson who may develop kidney failure 10–20 years in the future. [35] Mr. Hil, the founder of the NKR, was the second donor to donate his kidney through this program. In 2015, the National Kidney Registry completed 360 KPD transplants which accounted for 62% of all U.S. KPD transplants and more than the combined volume of all other KPD programs in world.

Outcomes

Concerns regarding the negative impact that Cold Ischemic Time (CIT) may have on graft survival, due to the shipment of the kidneys, initially caused concern in the transplant industry and slowed the adoption of KPD. This concern regarding CIT originated from deceased donor transplant experiences where greater CIT is correlated with lower graft survival rates. [36] Prior to KPD, there was no reason to ship living donor kidneys and therefore, there was no understanding of the impact of CIT on outcomes. This concern proved to be unfounded as more living donor kidneys were shipped and the research demonstrated that CIT had no negative impact on KPD outcomes. [37] [38]

After completing over 1,000 KPD transplants, it was discovered that NKR's graft survival rates were actually better than the graft survival rates of the typical U.S. non-KPD living donor transplants. [39] Researchers are working to better understand why NKR KPD transplants have superior outcomes and believe it may be driven by better HLA and donor age matching and/or better avoidance of recipient antibodies. Researchers have determined that the improved outcomes from NKR are not driven by a center effect although most of the top U.S. transplant centers participate in KPD via NKR. The improved outcomes from KPD transplants are opening the door for more compatible pair participation in KPD, allowing patient with compatible living donor to essentially trade-up and get a better matched kidney. The increasing enrollment of compatible pairs in KPD is shortening the wait times for incompatible pairs with hard to match blood type combinations (e.g. "O" patients with "A" donors) and driving more matches for highly sensitized patients (e.g. cPRAs > 90%).

Researchers have also discovered that better HLA matching not only leads to longer lasting transplants, [2] but is also correlated with lower patient mortality rates [1] [13] [40] because better matched kidneys require less immunosuppression and less immunosuppression reduces nephrotoxicity and other negative side effects from post-transplant anti-rejection medications. Equally important, better HLA matching reduces the number of antibodies that a transplant recipient will create making it easier to get a second, third or fourth transplant. [41] This issue is critical for young transplant recipients who have a life expectancy that is longer than the expected graft survival (i.e. how long a transplanted kidney lasts). Deceased donor kidneys typically last 5–15 years [42] and living donor kidneys typically last 10–30 years. [42]

Compatible pairs

When KPD first started, the focus was only on enrolling incompatible donor–recipient pairs. As paired exchange grew and the process became faster and more reliable, patients with compatible donors that wanted a better match, began enrolling in KPD. Researchers have identified that a better matched kidney is correlated with better outcomes. Specifically a better matched kidney lasts longer [2] and may allow for a lower dosage of post-transplant immunosuppressive medications. [2] Also a better matched kidney transplant is correlated with a lower lifetime mortality rate. [1] [13] [40]

For compatible pairs, not only does a better match lead to a better outcome, but it also directly helps other patients with incompatible donors find a match and get transplanted. A favorable blood type compatible pair (i.e. O donor with non-O recipient) will facilitate at least one and as many as six additional transplants. [39] Compatible pair participation is the fastest growing segment of KPD [39] and holds the promise of facilitating better matches for patients with compatible donors while limiting KPD wait times to less than 12 months for patients that have a cPRA ("Calculated panel reactive antibodies" [43] ) less than 98%.

Advanced Donation

Advanced Donation, [21] which began in 2012 and expanded in 2014 to include Voucher donations and swap saver cases, expanded so rapidly that by 2017 Advanced Donation accounted for nearly half of the chain starts in the United States. As adoption of Advanced Donation increased, due to the timing advantages that made donation surgery more convenient for the donor, the size and complexity of KPD swaps were reduced, with the logical extension of this trend being the eventual elimination of traditional chain and loop swaps, replaced by 1-deep chains.

See also

Related Research Articles

<span class="mw-page-title-main">Organ donation</span> Process of voluntarily giving away organs

Organ donation is the process when a person authorizes an organ of their own to be removed and transplanted to another person, legally, either by consent while the donor is alive, through a legal authorization for deceased donation made prior to death, or for deceased donations through the authorization by the legal next of kin.

<span class="mw-page-title-main">Organ transplantation</span> Medical procedure in which an organ is removed from one body and placed in the body of a recipient

Organ transplantation is a medical procedure in which an organ is removed from one body and placed in the body of a recipient, to replace a damaged or missing organ. The donor and recipient may be at the same location, or organs may be transported from a donor site to another location. Organs and/or tissues that are transplanted within the same person's body are called autografts. Transplants that are recently performed between two subjects of the same species are called allografts. Allografts can either be from a living or cadaveric source.

<span class="mw-page-title-main">Liver transplantation</span> Type of organ transplantation

Liver transplantation or hepatic transplantation is the replacement of a diseased liver with the healthy liver from another person (allograft). Liver transplantation is a treatment option for end-stage liver disease and acute liver failure, although availability of donor organs is a major limitation. The most common technique is orthotopic transplantation, in which the native liver is removed and replaced by the donor organ in the same anatomic position as the original liver. The surgical procedure is complex, requiring careful harvest of the donor organ and meticulous implantation into the recipient. Liver transplantation is highly regulated, and only performed at designated transplant medical centers by highly trained transplant physicians and supporting medical team. Favorable outcomes require careful screening for eligible recipients, as well as a well-calibrated live or deceased donor match.

<span class="mw-page-title-main">Transplant rejection</span> Rejection of transplanted tissue by the recipients immune system

Transplant rejection occurs when transplanted tissue is rejected by the recipient's immune system, which destroys the transplanted tissue. Transplant rejection can be lessened by determining the molecular similitude between donor and recipient and by use of immunosuppressant drugs after transplant.

<span class="mw-page-title-main">Kidney transplantation</span> Medical procedure

Kidney transplant or renal transplant is the organ transplant of a kidney into a patient with end-stage kidney disease (ESRD). Kidney transplant is typically classified as deceased-donor or living-donor transplantation depending on the source of the donor organ. Living-donor kidney transplants are further characterized as genetically related (living-related) or non-related (living-unrelated) transplants, depending on whether a biological relationship exists between the donor and recipient. The first successful kidney transplant was performed in 1954 by a team including Joseph Murray, the recipient's surgeon, and Hartwell Harrison, surgeon for the donor. Murray was awarded a Nobel Prize in Physiology or Medicine in 1990 for this and other work. In 2018, an estimated 95,479 kidney transplants were performed worldwide, 36% of which came from living donors.

<span class="mw-page-title-main">Canadian Blood Services</span> Canadian health non-profit

Canadian Blood Services is a non-profit charitable organization that is independent from the Canadian government. The Canadian Blood Services was established as Canada's blood authority in all provinces and territories except for Quebec in 1998. The federal, provincial and territorial governments created the Canadian Blood Services through a memorandum of understanding. Canadian Blood Services is funded mainly through the provincial and territorial governments.

<span class="mw-page-title-main">United Network for Organ Sharing</span>

The United Network for Organ Sharing (UNOS) is a non-profit scientific and educational organization that administers the only Organ Procurement and Transplantation Network (OPTN) in the United States, established by the U.S. Congress in 1984 by Gene A. Pierce, founder of United Network for Organ Sharing. Located in Richmond, Virginia, the organization's headquarters are situated near the intersection of Interstate 95 and Interstate 64 in the Virginia BioTechnology Research Park.

The National Marrow Donor Program (NMDP) is a nonprofit organization founded in 1987 and based in Minneapolis, Minnesota, that operates the Be The Match Registry of volunteer hematopoietic cell donors and umbilical cord blood units in the United States.

<span class="mw-page-title-main">National Organ Transplant Act of 1984</span>

The National Organ Transplant Act (NOTA) of 1984 is an Act of the United States Congress that created the framework for the organ transplant system in the country. The act provided clarity on the property rights of human organs obtained from deceased individuals and established a public-private partnership known as Organ Procurement and Transplantation Network (OPTN). The OPTN was given the authority to oversee the national distribution of organs.

Organ trade is the trading of human organs, tissues, or other body products, usually for transplantation. According to the World Health Organization (WHO), organ trade is a commercial transplantation where there is a profit, or transplantations that occur outside of national medical systems. There is a global need or demand for healthy body parts for transplantation, which exceeds the numbers available.

<span class="mw-page-title-main">Alvin E. Roth</span> American academic (born 1951)

Alvin Eliot Roth is an American academic. He is the Craig and Susan McCaw professor of economics at Stanford University and the Gund professor of economics and business administration emeritus at Harvard University. He was President of the American Economic Association in 2017.

"Harvest" is the 14th episode of the second season of the American television show Numbers. Inspired by a Christian Science Monitor article about organ tourists, people who travel to a different country to give their organs for money, and an algorithm developed in the United States, the episode features Federal Bureau of Investigation (FBI) agents and mathematicians attempting to locate a missing organ tourist before she is killed.

<span class="mw-page-title-main">Transplant glomerulopathy</span> Medical condition

Transplant glomerulopathy(TG) is a morphologic lesion of renal allografts that is histologically identified by glomerular basement membrane (GBM) duplication and/or multilayering. Proteinuria, hypertension, and deteriorating graft function are the hallmarks of TG.

ABO-incompatible (ABOi) transplantation is a method of allocation in organ transplantation that permits more efficient use of available organs regardless of ABO blood type, which would otherwise be unavailable due to hyperacute rejection. Primarily in use in infants and young toddlers, research is ongoing to allow for increased use of this capability in adult transplants. Normal ABO-compatibility rules may be observed for all recipients. This means that anyone may receive a transplant of a type-O organ, and consequently, type-O recipients are one of the biggest beneficiaries of ABO-incompatible transplants. While focus has been on infant heart transplants, the principles generally apply to other forms of solid organ transplantation.

Tayfun Sönmez is a Turkish-American professor of economics at Boston College. He is a Fellow of the Econometric Society and the 2008 winner of the Social Choice and Welfare Prize, which honors scholars under the age of 40 for excellent accomplishment in the area of social choice theory and welfare economics. Sönmez has made significant contributions in the areas of microeconomic theory, mechanism/market design, and game theory. His work has been featured by the U.S. National Science Foundation for its practical relevance.

The National Kidney Registry (NKR) is a national registry in the United States listing kidney donors and recipients in need of a kidney transplant. NKR facilitates over 450 "Kidney Paired Donation" (KPD) or "Paired Exchange" transplants annually.

<span class="mw-page-title-main">Dorry Segev</span> American surgeon

Dorry L. Segev is the head of the Center for Surgical and Transplant Applied Research at NYU Langone Health. Previously he served as the Marjory K. and Thomas Pozefsky Professor of Surgery at Johns Hopkins School of Medicine, professor of epidemiology at Johns Hopkins Bloomberg School of Public Health, and associate vice chair of the Department of Surgery at Johns Hopkins Hospital. He has made significant contributions to the field of transplantation, including developing a mathematical model to facilitate a nationwide kidney paired donation program, both in the US and Canada. He is also known for his role in getting the HIV Organ Policy Equity Act signed into law.

Donor-specific antibodies (DSA) are a concept in transplantation medicine and describe the presence of antibodies specific to the Donor's HLA-Molecules. These antibodies can cause antibody-mediated rejection and are therefore considered a contraindication against transplantation in most cases. DSA are a result of B cell and plasma cell activation and bind to HLA and/or non-HLA molecules on the endothelium of the graft. They were first described in 1969 by Patel et al., who found that Transplant recipients who were positively tested for DSA using a complement-dependent cytotoxicity crossmatch assay had a higher risk of transplant rejection. DSA can either be pre-formed or can be formed as a response to the transplantion.

<span class="mw-page-title-main">Priyadarshi Ranjan</span>

Priyadarshi Ranjan is an Indian urologist, robotic surgery specialist, kidney transplant surgeon, and researcher. He is commonly perceived as the "Kidney Man of India". He is among the top 10 transplant surgeons across the globe who is certified of performing a Robotic Kidney Transplant. Currently, regarded as one of the pioneering leads for kidney transplantation across the globe.

Optimal kidney exchange (OKE) is an optimization problem faced by programs for kidney paired donations (also called Kidney Exchange Programs). Such programs have large databases of patient-donor pairs, where the donor is willing to donate a kidney in order to help the patient, but cannot do so due to medical incompatibility. The centers try to arrange exchanges between such pairs. For example, the donor in pair A donates to the patient in pair B, the donor in pair B donates to the patient in pair C, and the donor in pair C donates to the patient in pair A.

References

  1. 1 2 3 4 "Compatible Pairs - National Kidney Registry - Facilitating Living Donor Transplants". kidneyregistry.org. Retrieved 2016-08-26.
  2. 1 2 3 4 5 Milner; Melcher; Lee; Veale; Ronin; D'Alessandro; Hil; Fry; Shannon (2016-07-15). "HLA Matching Trumps Donor Age: Donor-Recipient Pairing Characteristics that Impact Long-Term Success In Living Donor Kidney Transplantation in the Era of Paired Kidney Exchange". Transplantation Direct. 2 (7): e85. doi:10.1097/TXD.0000000000000597. PMC   5087568 . PMID   27830179.
  3. ↑ Kidney Transplant Activity from Living Donors in 2010 (Absolute Numbers, 81 Countries) (Report). Global Observatory on Donation and Transplantation. Retrieved 1 Jun 2016.
  4. ↑ Transplant:Donor Relation by Transplant Center (Report). Organ Procurement and Transplantation Network. Retrieved 6 Apr 2016.
  5. ↑ Paired Exchange Results Quarterly Report (Report). National Kidney Registry. 2015.
  6. 1 2 3 Sack, Kevin (18 Feb 2012). "60 Lives, 30 Kidneys, All Linked". New York Times.
  7. 1 2 3 Pitts; Louszko; Cappetta; Effron; Valiente (15 Apr 2015). "Changing Lives Through Donating Kidneys to Strangers". ABC News Nightline.
  8. 1 2 3 4 5 6 7 8 9 Ellison, Blake (2014-05-16). "A Systematic Review of Kidney Paired Donation: Applying Lessons From Historic and Contemporary Case Studies to Improve the US Model". Wharton Research Scholars Journal. 107. Retrieved 2016-08-23.
  9. ↑ "100th living donor kidney transplant arranged through OPTN/UNOS KPDPP | UNOS". www.unos.org. 2014-07-10. Retrieved 2016-09-12.
  10. ↑ "About Alliance for Paired Kidney Donation : Matching Donors". paireddonation.org. 11 August 2015. Retrieved 2016-09-12.
  11. ↑ Teltser, Keith F. (2019). "Do Kidney Exchanges Improve Patient Outcomes?". American Economic Journal: Economic Policy. 11 (3): 427–453. doi:10.1257/pol.20170678. ISSN   1945-7731.
  12. ↑ Segev; Gentry; Warren; Reeb; Montgomery (20 Apr 2005). "Kidney Paired Donation and Optimizing the Use of Live Donor Organs" (PDF). JAMA. 293 (15): 1883–1890. doi: 10.1001/jama.293.15.1883 . PMID   15840863.
  13. 1 2 3 Opelz, G.; Döhler, B. (2012-11-01). "Association of HLA mismatch with death with a functioning graft after kidney transplantation: a collaborative transplant study report". American Journal of Transplantation. 12 (11): 3031–3038. doi: 10.1111/j.1600-6143.2012.04226.x . ISSN   1600-6143. PMID   22900931.
  14. 1 2 Wallis; Samy; Roth; Rees (31 Mar 2011). "Kidney paired donation". Nephrology, Dialysis, Transplantation. 26 (7). Nephrol Dial Transplant (2011): 2091–2099. doi: 10.1093/ndt/gfr155 . PMID   21454351.
  15. ↑ "Johns Hopkins Gazette | November 27, 2006". pages.jh.edu. Retrieved 2016-08-26.
  16. 1 2 Rees, Michael A.; Kopke, Jonathan E.; Pelletier, Ronald P.; Segev, Dorry L.; Rutter, Matthew E.; Fabrega, Alfredo J.; Rogers, Jeffrey; Pankewycz, Oleh G.; Hiller, Janet (2009-03-12). "A Nonsimultaneous, Extended, Altruistic-Donor Chain". New England Journal of Medicine. 360 (11): 1096–1101. doi: 10.1056/NEJMoa0803645 . ISSN   0028-4793. PMID   19279341. S2CID   2581617.
  17. 1 2 "H.R. 710 (110^th): Charlie W. Norwood Living Organ Donation Act". govtrack. 21 Dec 2007.
  18. ↑ "National Kidney Registry". 2008-02-20. Retrieved 2016-08-26.
  19. ↑ "Johns Hopkins Leads First 16-Patient, Multicenter "Domino Donor" Kidney Transplant". Johns Hopkins Medicine. 7 Jul 2009.
  20. ↑ "16 patients, 8 'new' kidneys, 4 hospitals: Johns Hopkins surgeons lead largest-ever 'domino donor' kidney transplant". The JHU Gazette. 20 Jul 2009. Archived from the original on 4 May 2017. Retrieved 1 June 2016.
  21. 1 2 Veale, Jeffrey L.; Capron, Alexander M.; Nassiri, Nima; Danovitch, Gabriel; Gritsch, H. Albin; Waterman, Amy; Del Pizzo, Joseph; Hu, Jim C.; Pycia, Marek (September 2017). "Vouchers for Future Kidney Transplants to Overcome "Chronological Incompatibility" Between Living Donors and Recipients". Transplantation. 101 (9): 2115–2119. doi:10.1097/TP.0000000000001744. ISSN   1534-6080. PMID   28333861. S2CID   3325450.
  22. ↑ Rapaport, F. T. (June 1986). "The case for a living emotionally related international kidney donor exchange registry". Transplantation Proceedings. 18 (3) Suppl. 2): 5–9. ISSN   0041-1345. PMID   11649919.
  23. ↑ "Hopkins Medicine Magazine - Circling the Dome". www.hopkinsmedicine.org. Retrieved 2016-08-26.
  24. ↑ "Alvin Roth". 2008-09-01. Retrieved 2016-08-26.
  25. ↑ "Steve Woodle, MD". www.cecentral.com. Retrieved 2016-08-26.
  26. ↑ "About Alliance for Paired Kidney Donation : Matching Donors". paireddonation.org. 11 August 2015. Retrieved 2016-08-26.
  27. ↑ "Hopkins Performs Historic "Six-Way Domino" Kidney Transplant - 04/08/2008" . Retrieved 2016-08-25.
  28. ↑ "National Organ Transplant Act" (PDF). 1984-10-19. Retrieved 2016-08-23.
  29. ↑ "United Network for Organ Sharing" (PDF). Retrieved 2016-08-25.
  30. ↑ "First NY–to–LA living-donor transplant chain results in triple kidney transplant". www.uclahealth.org. Retrieved 2016-08-25.
  31. ↑ "NKR Introduces GPS Tracking Technology". National Kidney Registry. Retrieved 2016-08-23.
  32. ↑ "National Kidney Registry Initiates Donor Blood Cryo-Preservation". National Kidney Registry. 2014-12-02.
  33. ↑ "United Network for Organ Sharing" (PDF). Retrieved 2016-08-26.
  34. ↑ Flechner, S. M.; Leeser, D.; Pelletier, R.; Morgievich, M.; Miller, K.; Thompson, L.; McGuire, S.; Sinacore, J.; Hil, G. (2015-10-01). "The Incorporation of an Advanced Donation Program Into Kidney Paired Exchange: Initial Experience of the National Kidney Registry". American Journal of Transplantation. 15 (10): 2712–2717. doi: 10.1111/ajt.13339 . ISSN   1600-6143. PMID   26012533. S2CID   7329106.
  35. ↑ Rivero, Enrique. "'Gift certificate' enables kidney donation when convenient and transplant when needed". UCLA Newsroom. Retrieved 2016-08-25.
  36. ↑ Debout, Foucher, Trebern-Launay, Legendre, Kreis, Mourad, Garrigue, Morelon, Buron, Rostaing, Kamar, Kessler, Ladrie, Poignas, Blidi, Soulillou, Giral, Dantan (2014-09-17). "Each additional hour of cold ischemia time significantly increases the risk of graft failure and mortality following renal transplantation". Kidney International. 87 (2): 343–349. doi: 10.1038/ki.2014.304 . PMID   25229341 . Retrieved 2016-08-23.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  37. ↑ Butt, F. K.; Gritsch, H. A.; Schulam, P.; Danovitch, G. M.; Wilkinson, A.; Del Pizzo, J.; Kapur, S.; Serur, D.; Katznelson, S. (2009-09-01). "Asynchronous, out-of-sequence, transcontinental chain kidney transplantation: a novel concept". American Journal of Transplantation. 9 (9): 2180–2185. doi:10.1111/j.1600-6143.2009.02730.x. ISSN   1600-6143. PMID   19563335.
  38. ↑ Treat, Miller, Kwan, Connon, Maliski, Hicks, Williams, Whitted, Gritsch, McGuire, Mone, Veale (2014-09-22). "Outcomes of shipped live donor kidney transplants compared with traditional living donor kidney transplants". Transplant International. 27 (11): 1175–82. doi:10.1111/tri.12405. PMID   25052215. S2CID   2156607.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  39. 1 2 3 "National Kidney Registry" . Retrieved 2016-08-23.
  40. 1 2 Cecka, J Michael (2007-04-01). "Does flow cytometry crossmatch predict renal allograft outcome in patients with a negative antiglobulin crossmatch?". Nature Clinical Practice Nephrology. 3 (3): 136–137. doi:10.1038/ncpneph0405. ISSN   1745-8331. PMID   17262074. S2CID   38509513.
  41. ↑ Meier-Kriesche, Herwig-Ulf; Scornik, Juan C.; Susskind, Brian; Rehman, Shehzad; Schold, Jesse D. (2009-07-15). "A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients". Transplantation. 88 (1): 23–29. doi: 10.1097/TP.0b013e3181a9ec89 . ISSN   1534-6080. PMID   19584676. S2CID   970714.
  42. 1 2 "Organ Procurement and Transplantation Network and Scientific Registry of Transplant Recipients 2010 Data Report". American Journal of Transplantation. 12: 1–156. 2012-01-01. doi: 10.1111/j.1600-6143.2011.03886.x . ISSN   1600-6143. PMID   22107249. S2CID   11614703.
  43. ↑ "Medical Board Policies". National Kidney Registry. Retrieved 2023-05-06.

Further reading

The following academic publications highlight the most significant innovations and results in the field of KPD.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.